Treatment patterns, survival, and healthcare utilisation and costs in patients with locally advanced and metastatic bladder cancer in Denmark 2015-2020

CONCLUSION: Patients with La/mUBC have a poor prognosis, and in routine clinical care only around half of the patients received systemic anti-cancer treatment suggesting an unmet need for novel treatments. The overall costs only increased slightly from first to third-line treatment.PMID:37787748 | DOI:10.1080/0284186X.2023.2263154

https://pubmed.ncbi.nlm.nih.gov/37787748/?utm_source=no_user_agent&utm_medium=rs...

Source: Acta Oncologica - October 3, 2023 Category: Cancer & Oncology Authors: Mette N ørgaard Aur élie Mailhac Karin Fagerlund Torsten Strunz-McKendry Mads Agerb æk J ørgen Bjerggaard Jensen Source Type: research